title: Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease?
authors: 1 Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France 2 CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France erwan.bezard@u-bordeaux.fr.
authors: Erwan
authors: E
authors: Bezard
authors: 3 Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy.
authors: Manolo
authors: M
authors: Carta
mesh_terms: D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*
chemical_list: D010879:Piperazines; D007980:Levodopa; C063828:eltoprazine